Expanding organ availability by using hepatitis C antibody positive donors.
Aswad
S
S
National Institute of Transplantation, Los Angeles, California 90057.
Mendez
R
R
Weingart
R G
RG
Mendez
R
R
D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005500:Follow-Up Studies; D016174:Hepacivirus; D006508:Hepatitis Antibodies / Q000097:blood*; D006526:Hepatitis C / Q000097:blood / Q000503:physiopathology* / Q000635:transmission; D018937:Hepatitis C Antibodies; D006801:Humans; D016030:Kidney Transplantation / Q000502:physiology*; D008111:Liver Function Tests; D008297:Male; D013997:Time Factors; D014019:Tissue Donors / Q000600:supply & distribution*
D006508:Hepatitis Antibodies; D018937:Hepatitis C Antibodies; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D001663:Bilirubin